Rayne Helen Rouce MD
Clinical Postdoc Fellow, Pediatric Hematology & Oncology, Baylor College of Medicine
Join to View Full Profile
301 University BlvdGalveston, TX 77555
Phone+1 409-772-4194
Dr. Rouce is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2011 - 2014
University of Texas Medical Branch HospitalsResidency, Pediatrics, 2007 - 2010
University of Texas Medical Branch School of MedicineClass of 2007
Certifications & Licensure
TX State Medical License 2010 - 2026
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen Start of enrollment: 2017 Nov 01
- Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed on Autologous T Cells Start of enrollment: 2021 Aug 02
- CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA) Start of enrollment: 2022 Jun 01
Publications & Presentations
PubMed
- Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas.Yomani D Sarathkumara, Nathan W Van Bibber, Zhiwei Liu, Helen E Heslop, Rayne H Rouce
Blood Advances. 2025-04-08 - How to democratize cell and gene therapy: a global approach.Rayne H Rouce, Bambi J Grilley
Molecular Therapy. 2025-04-02 - Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors.Aaron B Ross, Kriti Puri, Thomas L Johnson, Lilliam D Correa, Tami D John
Pediatric Blood & Cancer. 2025-04-01
Journal Articles
- EBV/LMP-specific T Cells Maintain Remissions of T and B Cell EBV Lymphomas After Allogeneic Bone Marrow TransplantationStephen Gottschalk, Rayne Rouce, Catherine M Bollard, Malcolm K Brenner, Helen E Heslop, Blood
Abstracts/Posters
- Safety and Anti-Tumor Activity of CD5 CAR T-Cells in Patients with Relapsed/Refractory T-Cell MalignanciesClinically Relevant AbstractRayne H. Rouce, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Genomic Characterization of a Pediatric Cohort with Non-Malignant Lymphoproliferative DisordersRayne H. Rouce, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Are We There Yet? A Cancer Cure May Be Just a CAR Ride AwayNational Conference & Exhibition 2019 - American Academy of Pediatrics - New Orleans, LA - 10/28/2019
- BMT Peds and Adult61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Targeting Lymphomas Using Non-Engineered, Multi-Antigen Specific T Cells2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Cell Therapy Pioneer: Modality Could Be Solution to ‘Pretty Large Cadre’ of DiseasesOctober 17th, 2022
‘Swag Worthy’ Doctor Splits Time Between Patients, Rap MusicFebruary 3rd, 2021
Stand up to Cancer Dream Team Tackles T-cell Lymphoma, Focused on CAR-Based StrategiesJanuary 28th, 2019- Join now to see all
Grant Support
- 1/2 Collaborative Union for Cancer Research, Education and Disparities (CURED)BAYLOR COLLEGE OF MEDICINE2023–2027
- 2/2 Collaborative Union for Cancer Research, Education, and Disparities (CURED)TEXAS SOUTHERN UNIVERSITY2023–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
